Lymphoma, T-Cell

"Lymphoma, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.

Descriptor ID	D016399
MeSH Number(s)	C04.557.386.480.750 C15.604.515.569.480.750 C20.683.515.761.480.750
Concept/Terms	Lymphoma, T-Cell Lymphoma, T-Cell Lymphoma, T Cell T-Cell Lymphoma Lymphomas, T-Cell T Cell Lymphoma T-Cell Lymphomas

Below are MeSH descriptors whose meaning is more general than "Lymphoma, T-Cell".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Lymphoma, T-Cell [C04.557.386.480.750]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Lymphoma, T-Cell [C15.604.515.569.480.750]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]
Lymphoma, T-Cell [C20.683.515.761.480.750]

Below are MeSH descriptors whose meaning is related to "Lymphoma, T-Cell".

Below are MeSH descriptors whose meaning is more specific than "Lymphoma, T-Cell".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoma, T-Cell" by people in this website by year, and whether "Lymphoma, T-Cell" was a major or minor topic of these publications.

Bar chart showing 25 publications over 13 distinct years, with a maximum of 3 publications in 2002 and 2007 and 2008 and 2009 and 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
2002	2	1	3
2003	1	0	1
2004	0	1	1
2006	1	0	1
2007	2	1	3
2008	3	0	3
2009	3	0	3
2010	2	1	3
2011	1	0	1
2014	1	1	2
2016	2	0	2
2017	1	0	1

Below are the most recent publications written about "Lymphoma, T-Cell" by people in Profiles.

Tan Y, Sementino E, Xu J, Pei J, Liu Z, Ito TK, Cai KQ, Peri S, Klein-Szanto AJ, Wiest DL, Testa JR. The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling. Oncotarget. 2017 Feb 28; 8(9):14941-14956.

View in: PubMed
Lesokhin AM, Ansell SM, Armand P, Scott EC, Halwani A, Gutierrez M, Millenson MM, Cohen AD, Schuster SJ, Lebovic D, Dhodapkar M, Avigan D, Chapuy B, Ligon AH, Freeman GJ, Rodig SJ, Cattry D, Zhu L, Grosso JF, Bradley Garelik MB, Shipp MA, Borrello I, Timmerman J. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study. J Clin Oncol. 2016 08 10; 34(23):2698-704.

View in: PubMed
Rao S, Cai KQ, Stadanlick JE, Greenberg-Kushnir N, Solanki-Patel N, Lee SY, Fahl SP, Testa JR, Wiest DL. Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma. Cancer Res. 2016 06 01; 76(11):3387-96.

View in: PubMed
Gorcey L, Lewin JM, Trufant J, Meehan SA, McLellan BN. Papular eruption associated with palifermin. J Am Acad Dermatol. 2014 Sep; 71(3):e101-2.

View in: PubMed
Herrera AF, Crosby-Thompson A, Friedberg JW, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Millenson MM, Nademanee AP, Niland JC, Rodig SJ, Rodriguez MA, Zelenetz AD, LaCasce AS. Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network. Cancer. 2014 Jul 01; 120(13):1993-9.

View in: PubMed
Pro B. Recent advances in the treatment of T-cell lymphoma. Clin Adv Hematol Oncol. 2011 Apr; 9(4 Suppl 8):1-16.

View in: PubMed
Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN. Cutaneous CD4+ CD56+ hematologic malignancies. J Am Acad Dermatol. 2010 Aug; 63(2):292-308.

View in: PubMed
Pro B, Horwitz SM, Atmar JP. Clinical roundtable monograph. Current management and treatment of T-cell lymphoma: A multidisciplinary approach. Clin Adv Hematol Oncol. 2010 Jun; 8(6):suppl 1-15.

View in: PubMed
Erter J, Alinari L, Darabi K, Gurcan M, Garzon R, Marcucci G, Bechtel MA, Wong H, Porcu P. New targets of therapy in T-cell lymphomas. Curr Drug Targets. 2010 Apr; 11(4):482-93.

View in: PubMed
Pozadzides JV, Pro B. Hepatosplenic T-cell lymphoma and TNF-a inhibitors. Expert Rev Hematol. 2009 Dec; 2(6):611-4.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement